Patient Square Capital
ZLAB icon

Patient Square Capital’s Zai Lab ZLAB Stock Holding History

Patient Square Capital’s Portfolio ZLAB Stock Details ZLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$15.6M Buy
+591,510
New +$13.7M 2.49% 9

Other funds holding ZLAB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
C WorldWide Group
C WorldWide Group Copenhagen, Denmark $3.96B AUM 10.41% 1-Year Est. Return
Nan Fung Trinity
Nan Fung Trinity Central, Hong Kong, Hong Kong $1.04B AUM 32.17% 1-Year Est. Return
Hennion & Walsh Asset Management
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 31.32% 1-Year Est. Return
ALPS Advisors
ALPS Advisors Denver, Colorado $21.8B AUM 17.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
WealthPlan Investment Management
WealthPlan Investment Management Omaha, Nebraska $2.07B AUM 21.2% 1-Year Est. Return
DA
DCF Advisers Greenwich, Connecticut $444M AUM 151.5% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return

Patient Square Capital's ZLAB Position: Q3 2026 in Review

Patient Square Capital opened a new position in Zai Lab (ZLAB) in Q3 2026: 591,510 shares worth $15.6M. The stake represents 2.49% of the portfolio and ranks #9 among its holdings.

33 funds tracked by Wall St. Rank hold ZLAB as of Q3 2026.

  • Patient Square Capital held 591,510 shares of Zai Lab worth $15.6M as of Q3 2026.
  • Zai Lab was a new Patient Square Capital position in Q3 2026.
  • Zai Lab made up 2.49% of Patient Square Capital's portfolio in Q3 2026, its #9 holding.
  • 33 funds tracked by Wall St. Rank held Zai Lab as of Q3 2026.

Based on Patient Square Capital's 13F filing for Q3 2026, filed 10 Nov 2026.